FDA inspection
Chemco Corporation: FDA inspection ending Oct 31, 2022
FDA inspection 1182348 · Official Action Indicated (OAI) · Miami Lakes, FL
Key facts
| Inspection ID | 1182348 |
|---|---|
| Firm | Chemco Corporation |
| FEI number | 1042599 |
| Address | 4920 Nw 165th St |
| City | Miami Lakes |
| State | FL |
| ZIP | 33014-6323 |
| Fiscal year | 2023 |
| Inspection end date | Oct 31, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs|Over-the-Counter Drug Evaluation|Unapproved and Misbranded Drugs |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data